Acknowledgement
This study was supported by a grant from the National Research Foundation of Korea (2019R1G1A1100671).
References
- World Health Organization. WHO coronavirus (COVID-19) dashboard: Republic of Korea [Internet]. Geneva: World Health Organization; 2023 [cited 2023 Jan 23]. Available from: https://covid19.who.int/region/wpro/country/kr
- Hilbrands LB, Duivenvoorden R, Vart P, et al. COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration. Nephrol Dial Transplant 2020;35:1973-83. https://doi.org/10.1093/ndt/gfaa261
- Park HC, Lee YK, Ko E, et al. COVID-19-related clinical outcomes among Korean hemodialysis patients. Kidney Res Clin Pract 2022;41:591-600. https://doi.org/10.23876/j.krcp.22.023
- Chi C, Patel P, Pilishvili T, Moore M, Murphy TG, Strikas R. Guidelines for vaccinating kidney dialysis patients and patients with chronic kidney disease: summarized from recommendations of the Advisory Committee on Immunization Practices (ACIP) [Internet]. Atlanta (GA): Centers for Disease Control and Prevention; 2012 [cited 2022 Jun 6]. Available from: https://www.cdc.gov/vaccines/pubs/downloads/dialysis-guide-2012.pdf
- Carr EJ, Kronbichler A, Graham-Brown M, et al. Review of early immune response to SARS-CoV-2 vaccination among patients with CKD. Kidney Int Rep 2021;6:2292-304. https://doi.org/10.1016/j.ekir.2021.06.027
- Agur T, Ben-Dor N, Goldman S, et al. Antibody response to mRNA SARS-CoV-2 vaccine among dialysis patients: a prospectivecohort study. Nephrol Dial Transplant 2021;36:1347-9. https://doi.org/10.1093/ndt/gfab155
- Ikizler TA, Coates PT, Rovin BH, Ronco P. Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy. Kidney Int 2021;99:1275-9. https://doi.org/10.1016/j.kint.2021.04.007
- El Karoui K, Hourmant M, Ayav C, et al. Vaccination and COVID-19 dynamics in dialysis patients. Clin J Am Soc Nephrol 2022;17:395-402. https://doi.org/10.2215/CJN.10300721
- Ashby DR, Caplin B, Corbett RW, et al. Severity of COVID-19 after vaccination among hemodialysis patients: an observational cohort study. Clin J Am Soc Nephrol 2022;17:843-50. https://doi.org/10.2215/CJN.16621221
- Hsu CM, Weiner DE, Manley HJ, et al. Seroresponse to SARS-CoV-2 vaccines among maintenance dialysis patients over 6 months. Clin J Am Soc Nephrol 2022;17:403-13. https://doi.org/10.2215/CJN.12250921
- WHO Collaborating Centre for Vaccine Safety. How quickly does the vaccine work and how long does the protection last? [Internet]. Santiago de Compostela: WHO Collaborating Centre for Vaccine Safety; 2021 [cited 2023 Jan 23]. Available from: https://www.covid19infovaccines.com/en-posts/how-quickly-does-the-vaccine-work-and-how-long-does-the-protection-last
- Shin HJ, Cho MS, Jung SU, et al. Molecular cloning and characterization of a gene encoding a 13.1 kDa antigenic protein of Naegleria fowleri. J Eukaryot Microbiol 2001;48:713-7. https://doi.org/10.1111/j.1550-7408.2001.tb00211.x
- Lee HJ, Jung J, Lee JH, Lee DG, Kim YB, Oh EJ. Comparison of six serological immunoassays for the detection of SARS-CoV-2 neutralizing antibody levels in the vaccinated population. Viruses 2022;14:946.
- Lee SW, Moon JY, Lee SK, et al. Anti-SARS-CoV-2 spike protein RBD antibody levels after receiving a second dose of ChAdOx1 nCov-19 (AZD1222) vaccine in healthcare workers: lack of association with age, sex, obesity, and adverse reactions. Front Immunol 2021;12:779212.
- El Karoui K, De Vriese AS. COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment. Kidney Int 2022;101:883-94. https://doi.org/10.1016/j.kint.2022.01.022
- Anand S, Montez-Rath ME, Han J, et al. Antibody response to COVID-19 vaccination in patients receiving dialysis. J Am Soc Nephrol 2021;32:2435-8. https://doi.org/10.1681/ASN.2021050611
- Van Praet J, Reynders M, De Bacquer D, et al. Predictors and dynamics of the humoral and cellular immune response to SARS-CoV-2 mRNA vaccines in hemodialysis patients: a multicenter observational study. J Am Soc Nephrol 2021;32:3208-20. https://doi.org/10.1681/ASN.2021070908
- Grupper A, Sharon N, Finn T, et al. Humoral response to the Pfizer BNT162b2 vaccine in patients undergoing maintenance hemodialysis. Clin J Am Soc Nephrol 2021;16:1037-42. https://doi.org/10.2215/CJN.03500321
- Yanay NB, Freiman S, Shapira M, et al. Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients. Kidney Int 2021;99:1496-8. https://doi.org/10.1016/j.kint.2021.04.006
- Cha HH, Lim SY, Kwon JS, et al. Comparison of antibody responses after the 1st and 2nd doses of COVID-19 vaccine with those of patients with mild or severe COVID-19. Korean J Intern Med 2022;37:455-9. https://doi.org/10.3904/kjim.2021.409
- Bensouna I, Caudwell V, Kubab S, et al. SARS-CoV-2 antibody response after a third dose of the BNT162b2 vaccine in patients receiving maintenance hemodialysis or peritoneal dialysis. Am J Kidney Dis 2022;79:185-92. https://doi.org/10.1053/j.ajkd.2021.08.005
- Leavey SF, Strawderman RL, Jones CA, Port FK, Held PJ. Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis 1998;31:997-1006. https://doi.org/10.1053/ajkd.1998.v31.pm9631845
- Shankar S, Beckett J, Tipton T, et al. SARS-CoV-2-specific T cell responses are not associated with protection against reinfection in hemodialysis patients. J Am Soc Nephrol 2022;33:883-7. https://doi.org/10.1681/ASN.2021121587